Navigation Links
Regulus Reports Second Quarter 2014 Financial Results and Recent Highlights
Date:8/6/2014

lus expects to report human proof-of-concept results in the Phase I clinical study of RG-101 for the treatment of HCV by the end of 2014, initiate a Phase I clinical study of RG-012 for the treatment of Alport syndrome in the first half of 2015, nominate a third microRNA candidate for clinical development by the end of 2014, and maintain a strong financial position and end 2014 with at least $75.0 million in cash, cash equivalents and short-term investments.

About RegulusRegulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is uniquely positioned to leverage a mature therapeutic platform that harnesses the oligonucleotide drug discovery and development expertise of Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc., which founded the company.
Regulus has a well-balanced microRNA therapeutics pipeline entering clinical development, an emerging microRNA biomarkers platform to support its therapeutic programs, and a rich intellectual property estate to retain its leadership in the microRNA field.  Regulus intends to focus its proprietary efforts on developing microRNA therapeutics for oncology indications and orphan diseases and is currently advancing several programs toward clinical development in oncology, fibrosis and metabolic diseases.  Specifically, Regulus is developing RG-012, an anti-miR targeting microRNA-21 for the treatment of Alport syndrome, a life-threatening kidney disease driven by genetic mutations with no approved therapy, and RG-101, a GalNAc-conjugated anti-miR targeting microRNA-122 for the treatment of chronic hepatitis C virus infection.  Regulus' commitment to innovation and its leadership in the microRNA field have enabled the formation of strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec focused on microRNA biomark
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis
2. Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome
3. Regulus Announces Addition to NASDAQ Biotechnology Index
4. Regulus Reports Third Quarter 2013 Financial Results and Recent Highlights
5. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
6. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
7. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
8. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
9. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
10. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
11. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, ... devices, has developed and manufactured a new innovative ... the Research and Development arm of Exeltis Pharmaceuticals.  ... of Project Management at Particle Sciences, "This vaginal ... utilizing our material sciences and modeling expertise.  We ...
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
(Date:11/21/2014)...  Heated dialogue in recent months about the rising ... to Gilead,s new hepatitis C drug Harvoni® – has ... what it means to put a price on patient ... while drug pricing is one of the most debated ... general business and ethical standpoint – it is also ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5
... Inc. (NasdaqGM: MSON), a medical device company that ... worldwide for wound debridement, spinal surgery, cosmetic surgery, ... today the retention of Lytham Partners, LLC to ... Michael A. McManus, Jr., President and Chief ...
... Mass., Jan. 24, 2012  Mevion Medical Systems announced today ... ProQuest Investments and its existing investors, including Caxton Heath ... the manufacturer of the MEVION S250 Proton Therapy System. ... and worldwide deployment of the MEVION S250. ...
Cached Medicine Technology:Misonix, Inc. Retains Lytham Partners for Investor Relations 2Misonix, Inc. Retains Lytham Partners for Investor Relations 3Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems 2Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems 3
(Date:11/24/2014)... (PRWEB) November 24, 2014 Global ... 6.19 billion by 2020, according to a new ... rates of cardiac arrhythmias clubbed with growing global ... this market. Though still in the budding stage, ... rise in usage rates in the recent times, ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 A ... , London's pre-eminent pain-relief service and massage therapy ... Sports Massage (ESM). This newest sports massage ... The key difference between traditional sports massage and ... access the body's very own "reset button,” and ...
(Date:11/24/2014)... Raymond, Alberta (PRWEB) November 24, 2014 ... of people each day. They break up families, ... there is new hope for those that suffer,” ... “Ground-breaking scientific research is showing that our specialized ... , Hardy will appear on “Mind Over Matter”, ...
(Date:11/24/2014)... November 24, 2014 Dr. Michael Kettel ... Center, recently appeared on NBC to discuss egg freezing as ... has been trending in the news recently, with new company ... for women. , “[The companies] see it as ... on a career hot path.” Says Dr. Kettel. , Up ...
(Date:11/23/2014)... 2014 The report, “Market Snapshot: ... 2020 - Asia-Pacific” provides quantitative analysis of the ... minimally invasive body contouring devices, non-invasive body contouring ... market size data by revenue and volume over ... China, Japan, South Korea, Australia and India. It ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 3Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4
... black woman to be on AMA,s board , MONDAY, July ... he has nominated a rural Alabama family physician to be ... -- the first black woman and youngest doctor ever elected ... her resolve to rebuild her nonprofit medical clinic after it ...
... Leading hearing system ... their work on Hear the World, a global initiative to raise awareness about the importance ... ... the International Stevie Award for Communications Team of the Year for their work on Hear ...
... , , , ... http://www.avacor.com ) has acquired the assets ... Avacor,s FDA approved Physicians, Topical Formulation(R); the All-Natural Nutricap and Boost! ... which allows the company to market and sell the FDA approved ...
... 13, 2009) Twenty hematology and hematology/oncology fellows and ... mentoring program this summer as part of the American ... The ASH Clinical Research Training Institute provides aspiring hematologists ... research. The annual program begins with a week-long summer ...
... 13 CCA Industries, Inc. (NYSE Amex: CAW ), ... 2009 were $14,748,329, net income was $694,136 and earnings per share ... revenue of $17,389,985, net income of $790,692 and fully diluted ... Revenues for the six months ended May 31, 2009 were ...
... , WASHINGTON, July 13 As the health reform ... Future today released the names of prominent health care experts and economists ... insurance option to compete with private plans, but they are good sources ... , "Conservatives and health industry forces are putting ...
Cached Medicine News:Health News:Obama Taps Alabama Doctor to Be Surgeon General 2Health News:Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 2Health News:Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 3Health News:Avacor(R), Premier Provider of Hair Growth Solutions, Acquired By Investor Group. 2Health News:Promising hematologists begin year-long program to pursue careers in clinical research 2Health News:CCA Industries, Inc. Reports Second Quarter Earnings and Dividend for the Third Quarter. 2Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 2Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 3Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 4Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 5
... The OEV-143 Monitors are designed exclusively for ... use with all Olympus endoscopy systems. When ... equipment, the OEV-143 provides sharp, high-resolution images ... with the view - and details - ...
... Sony LMD-2140MD is a medical-grade, 21" LCD ... LMD2140MD incorporates a superb-quality LCD panel that ... contrast and color depth. This monitor provides ... input capabilities for analog or digital, SD ...
... monitors are designed specifically for medical environments. ... technology with professional monitors, the LMD-151MD offer ... safety requirements and are ideal for use ... more. Slim and light, they can be ...
Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time....
Medicine Products: